Russian registry of patients receiving rituximab: results of pharmacoeconomic analysis
Во всем мире продолжается разработка эффективных средств для диагностики и лечения ревматических заболеваний. В последнее десятилетие сделано большое количество открытий, созданы принципиально новые технологии, основанные на использовании достижений молекулярной биологии, которые позволяют значитель...
Saved in:
| Main Authors: | V N Amirdjanova, D V Goryachev, Sh F Erdes, E A Aseeva, G V Lukina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2009-02-01
|
| Series: | Научно-практическая ревматология |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/480 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE RUSSIAN REGISTRY OF RITUXIMAB. ANALYSIS OF THE EFFICIENCY OF THERAPY AND THE FUNCTIONAL STATEOF PATIENTS WITH RHEUMATOID ARTHRITIS
by: Vera Nikolayevna Amirdzhanova, et al.
Published: (2010-08-01) -
Combination therapy for rheumatoid arthritis with rituximab and leflunomide(preliminary results of the Russian ARBITR Registry)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2011-02-01) -
Quality of life in patients with rheumatoid arthritis receiving anti-В cell therapy (results of international studies and Russia registry)
by: V N Amirdjanova, et al.
Published: (2008-12-01) -
Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01) -
Pharmacoeconomic analysis of rituximab and belimumab therapy in patients with systemic lupus erythematosus
by: D. A. Gerasimova, et al.
Published: (2024-10-01)